康宁杰瑞制药-B（09966）今日盘中大涨5.03%，引起市场广泛关注。
消息面上，康宁杰瑞制药-B公布了截至2025年6月30日止的中期业绩报告，显示公司成功实现扭亏为盈，这一利好消息推动了股价的上涨。
根据公告，康宁杰瑞制药-B在2025年上半年实现营业额3.19亿元人民币，同比增长84%。公司扭亏为盈，实现股东应占溢利2157.5万元人民币，而去年同期亏损4489.6万元人民币。每股盈利为0.02元人民币。尽管业绩向好，公司决定本期不派息。这些积极的财务指标显示了公司经营状况的显著改善，增强了投资者对其未来发展的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.